TIRZEPATIDE/CYANOCOBALAMIN 64/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Roa Recall
Recall Date
Oct 14, 2026
Company
Carolina Infusion, LLC
Source
FDA
Units
29.6 mls - in patient specific syringe dose
Reason: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Official FDA recall noticeInformation is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.
Description
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Reason for Recall
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
What Should I Do?
Quantity: 29.6 mls - in patient specific syringe dose
5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.
+2 more steps…
Last updated October 21, 2026
Injured by a recalled product?
Our legal partners offer free consultations for recall victims.
Stay Informed
Weekly recall digest — free, no spam.